PRC2 loss drives MPNST metastasis and matrix remodelingQierra R. Brockman, Rebecca D. Dodd|JCI Insight|2022Cited by 21
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanismWade R. Gutierrez, Rebecca D. Dodd|JCI Insight|2022Cited by 9